Evidence map›Paper›PMID 26668598›Full record

ArticleExperimental and therapeutic medicine2015

Effect of

Zhi-Hua Zhao, Feng-Qi Li, Jian-Kui Han, Xian-Jun Li

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Experimental and therapeutic medicine, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Zhi-Hua ZhaoDepartment of Nuclear Medicine, Qilu Hospital, Shangdong University, Jinan, Shangdong 250012, P.R. China ; Department of Nuclear Medicine, Weifang People's Hospital, Weifang, Shandong 261041, P.R. China.
Feng-Qi LiDepartment of Nuclear Medicine, Weifang People's Hospital, Weifang, Shandong 261041, P.R. China.
Jian-Kui HanDepartment of Nuclear Medicine, Qilu Hospital, Shangdong University, Jinan, Shangdong 250012, P.R. China.
Xian-Jun LiDepartment of Nuclear Medicine, Weifang People's Hospital, Weifang, Shandong 261041, P.R. China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Thyroid cancer is a common malignant tumor of the endocrine glands. Although surgery is the optimal treatment utilized, the disease is characterized by recurrence and metastasis. The aim of the present study was to determine the effect of iodine-131 (

Indexed as

differentiated thyroid canceriodine-131 ‘clear residual thyroid tissue’ treatmentparathyroid functionthyroid globulin

Identifiers

PMID26668598
PMCPMC4665356

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.